5.2
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per…
Pleural effusion is the accumulation of fluid between the lungs and chest wall.
Based on protein content, it is classified into transudative or exudative types.
Transudative pleural effusions typically result from systemic factors that disrupt the hydrostatic or oncotic pressures in blood vessels, causing fluid to accumulate in the pleural space.
The most common cause is heart failure, where ineffective blood pumping increases venous pressure and causes fluid to leak into the pleural space.
Additionally, conditions like liver cirrhosis and nephrotic syndrome can both lower oncotic pressure. In cirrhosis, reduced albumin leads to fluid shifts, while in nephrotic syndrome, proteinuria lowers oncotic pressure, causing fluid buildup.
Exudative pleural effusions involve fluid accumulation with a higher protein content in the pleural space, often due to inflammation of the pleural membranes and increased vascular permeability.
Common causes like tuberculosis or pneumonia can inflame the pleura and accumulate exudative fluid.
Other causes include chest trauma, pulmonary embolism, malignancy, and autoimmune diseases, such as rheumatoid arthritis.
View the full transcript and gain access to JoVE Core videos
Q1: What is pleural effusion and why does it occur?
Pleural effusion is the abnormal accumulation of fluid between the lungs and chest wall in the pleural cavity. Normally, this space contains only 5 to 15 mL of lubricating fluid. Effusion occurs when systemic factors or inflammation disrupt the balance of hydrostatic and oncotic pressures, causing excess fluid to leak into the pleural space from blood vessels or inflamed pleural membranes.
Q2: How are transudative and exudative pleural effusions differentiated?
Transudative and exudative effusions are classified using Light's criteria, which measures protein and lactate dehydrogenase (LDH) levels in pleural fluid compared to serum. An effusion is exudative if pleural fluid protein/serum protein exceeds 0.5, pleural fluid LDH/serum LDH surpasses 0.6, or pleural fluid LDH exceeds two-thirds of the upper normal serum limit. Otherwise, it is transudative.
Q3: What causes transudative pleural effusions?
Transudative effusions result from systemic factors affecting blood vessel pressures. Congestive heart failure is the most common cause, where ineffective heart pumping increases venous pressure and fluid leaks into the pleural space. Liver cirrhosis reduces albumin production, lowering oncotic pressure. Nephrotic syndrome causes proteinuria, decreasing oncotic pressure and promoting fluid accumulation.
Q4: What are the main causes of exudative pleural effusions?
Exudative effusions develop from inflammation and increased permeability of pleural membranes. Common causes include pneumonia, which triggers inflammatory response; malignancy such as lung, breast, or mesothelioma; pulmonary embolism causing pleural irritation; connective tissue disorders like rheumatoid arthritis; and pulmonary infarction related to vasculitis or embolism.
Q5: How does heart failure lead to pleural fluid accumulation?
In congestive heart failure, the heart cannot pump blood effectively, causing venous pressure to increase. This elevated pressure forces fluid to leak from blood vessels into the pleural space, creating a transudative effusion. This mechanism disrupts the normal hydrostatic-oncotic pressure balance that maintains the pleural cavity's small fluid volume.
Q6: Why do liver cirrhosis and nephrotic syndrome cause pleural effusions?
Both conditions reduce oncotic pressure through different mechanisms. Liver cirrhosis decreases albumin production, lowering blood oncotic pressure and allowing fluid to shift into the pleural space. Nephrotic syndrome causes proteinuria, where excessive protein loss in urine reduces serum albumin and oncotic pressure, similarly promoting transudative fluid accumulation.
Q7: What role do pleural membranes play in exudative effusion development?
The pleural cavity is bounded by visceral and parietal pleural membranes. When these membranes become inflamed or their permeability increases due to infection, malignancy, or autoimmune disease, fluid with higher protein content accumulates in the pleural space. This increased vascular permeability allows fluid and proteins to leak from blood vessels into the pleural cavity.